Switching to biosimilar infliximab: real world data in patients with severe inflammatory arthritis.

Switching to biosimilar infliximab: real world data in patients with severe inflammatory arthritis.
Clin Exp Rheumatol. 2018 Jan 15;
Authors: Holroyd CR, Parker LM, Bennett S, Zarroug J, Underhill C, Davidson B, Armstrong R, Harvey NC, Dennison E, Cooper C, Edwards CJ
PMID: 29352847 [PubMed - as supplied by publisher]

Source: Clinical and Experimental Rheumatology - January 22, 2018 Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research